Location History:
- Baltimore, MD (US) (2005)
- Columbia, MD (US) (2010)
- Ellicott City, MD (US) (2001 - 2023)
Company Filing History:
18 out of 18 
1 out of 832,912 Years Active: 2001-2023
Title: Ginette Serrero: Innovating for the Future in Hematologic Research
Introduction
Ginette Serrero is a prolific inventor based in Ellicott City, Maryland, who has made significant contributions to the field of medical science. With 19 patents to his name, Serrero has focused primarily on developing innovative treatments and diagnostic tools targeting hematologic malignancies and related disorders.
Latest Patents
Among Serrero's most notable patents is one involving monoclonal antibodies and conjugates against prostaglandin F2 receptor inhibitors. This disclosure presents a valuable antibody that can be utilized for the diagnosis and treatment of conditions characterized by the expression of PTGFRN. Additionally, these antibodies may serve in imaging or detecting cells expressing PTGFRN, significantly enhancing diagnostic capabilities.
Another significant patent focuses on inhibiting the growth of hematopoietic malignant cells. This research presents compositions and methods aimed at reducing the growth of such cells by using GP88 antagonists, which inhibit the expression or activity of GP88, a known growth factor implicated in hematologic cancers. These developments also provide methods for assessing the efficacy of anti-cancer therapies based on GP88 levels in hematopoietic cells.
Career Highlights
Serrero has collaborated with various companies, including A&G Pharmaceutical, Inc., to advance his research efforts. His background encompasses both academic and corporate environments, enabling him to translate complex scientific concepts into practical applications effectively.
Collaborations
Collaboration has played an integral role in Serrero's career. Notable collaborators include esteemed colleagues such as Le Sun and Joe Corvera, who have supported his journey in developing innovative therapies and diagnostic techniques.
Conclusion
Ginette Serrero's contributions to hematologic research are noteworthy, and his 19 patents reflect a commitment to advancing medical science. As an inventor focused on critical health issues, his work has the potential to influence treatment approaches and improve patient outcomes in the future.